Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
124.15
+1.23 (1.00%)
At close: Mar 31, 2025, 4:00 PM
124.30
+0.15 (0.12%)
Pre-market: Apr 1, 2025, 6:58 AM EDT
Jazz Pharmaceuticals (JAZZ) Neroscience Revenue Breakdown
History
| Date | Xywav | Epidiolex | Xyrem | Sativex | Sunosi |
|---|---|---|---|---|---|
| Sep 30, 2024 | 1.41B | 938.00M | 291.25M | 18.84M | - |
| Jun 30, 2024 | 1.35B | 900.15M | 358.24M | 18.88M | - |
| Mar 31, 2024 | 1.31B | 855.28M | 455.83M | 15.31M | - |
| Dec 31, 2023 | 1.27B | 845.47M | 569.73M | 19.67M | - |
| Sep 30, 2023 | 1.22B | 811.84M | 710.51M | 19.25M | - |
| Jun 30, 2023 | 1.14B | 794.35M | 841.43M | 17.85M | - |
| Mar 31, 2023 | 1.05B | 767.41M | 951.09M | 19.18M | - |
| Dec 31, 2022 | 958.43M | 736.40M | 1.02B | 16.83M | - |
| Sep 30, 2022 | 859.70M | 723.19M | 1.06B | 16.75M | - |
| Jun 30, 2022 | 756.82M | 687.35M | 1.11B | 19.63M | 63.03M |
| Mar 31, 2022 | 645.96M | 621.54M | 1.18B | 17.45M | 62.19M |
| Dec 31, 2021 | 535.30M | 463.65M | 1.27B | 12.71M | 57.91M |
| Sep 30, 2021 | 367.91M | 269.86M | 1.42B | 8.06M | 51.70M |
| Jun 30, 2021 | 214.84M | 109.48M | 1.56B | 1.96M | 41.56M |
| Mar 31, 2021 | 90.68M | - | 1.67B | - | 38.02M |
| Dec 31, 2020 | 15.26M | - | 1.74B | - | 28.33M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.